Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy.

[1]  J. Mellors,et al.  HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  V. Calvez,et al.  Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy. , 2014, The Journal of antimicrobial chemotherapy.

[3]  G. Palù,et al.  A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects , 2013, BMC Infectious Diseases.

[4]  C. Rouzioux,et al.  Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. , 2013, The Journal of antimicrobial chemotherapy.

[5]  J. Arribas,et al.  Dynamics of Cellular HIV-1 DNA Levels Over 144 Weeks of Darunavir/Ritonavir Monotherapy Versus Triple Therapy in the MONET Trial , 2013 .

[6]  G. Palù,et al.  Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. , 2012, The Journal of antimicrobial chemotherapy.

[7]  L. Montaner,et al.  Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials , 2012, AIDS.

[8]  V. Calvez,et al.  Similar Evolution of Cellular HIV-1 DNA Level in Darunavir/Ritonavir Monotherapy versus Triple Therapy in MONOI –ANRS136 Trial over 96 Weeks , 2012, PloS one.

[9]  G. Palù,et al.  Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy , 2011, Journal of Clinical Microbiology.

[10]  C. Rouzioux,et al.  Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients , 2009, AIDS.

[11]  G. d’Ettorre,et al.  Cellular HIV‐1 DNA quantitation in patients during simplification therapy with protease inhibitor‐sparing regimens , 2007, Journal of medical virology.